Background/Aims-The fact that raised interleukin 1j (IL1l,) concentrations have been found in the colonic mucosa of rats with experimentally induced colitis and of patients with inflammatory bowel disease indicates that this cytokine may participate in the disturbed intestinal motility seen during inflammatory bowel disease. This study investigated whether IL13 could change the contractility of (a) a longitudinal muscle-myenteric plexus preparation from rat jejunum, ileum, and colon and (b) isolated jejunal smooth muscle cells. Methods-Isometric mechanical activity of intestinal segments was recorded using a force transducer. Moreover, smooth muscle cell length was measured by image analysis. Results-Although ILll did not affect jejunal, ileal, and colonic basal contractility, it significantly reduced contractile response to acetylcholine (ACh). This significant inhibition was seen only after 90 or 150 minutes of incubation with IL1 3. Pretreatment with cycloheximide blocked IL1 P induced inhibition of ACh stimulated jejunal contraction, suggesting that a newly synthesised protein was involved in the effect. Nw-nitro-L-arginine (a nitric oxide synthase inhibitor) did not prevent the inhibition induced by IL1(. Blocking neural transmission with tetrodotoxin abolished the IL1(3 effect on jejunal contractile activity, whereas IL1( had no effect on isolated and dispersed smooth muscle cells.
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Conclusions-IL1(3 inhibits ACh induced
intestinal contraction and this inhibitory effect involves protein synthesis but is independent ofnitric oxide synthesis. This effect does not involve a myogenic mechanism but is mediated through the myenteric plexus. have been found in the distal colonic mucosa of rats with experimentally induced colitis and in the intestine of patients with Crohn's disease.`A Intestinal inflammation in humans or animals is accompanied by motility changes, which may reflect alteration in the function of smooth muscle or the enteric nervous system, or both.5 IL 1 can also modulate the release of acetylcholine, norepinephrine, and substance P, which are neuromediators located in the rat myenteric plexus.68 Moreover, change in the colonic myoelectrical activity after induction of colitis with trinitrobenzene sulphonic acid was significantly reduced by an interleukin 1 receptor antagonist (ILl-ra).2 These findings suggest a role for endogenous ILl1 P as a mediator of changed neural function or motor activity in the inflamed intestine.
Few data concerning the effects of ILl1 P on intestinal motility are available in published reports, and its mechanism of action is not completely understood. In vivo, the central stimulatory action of endogenous IL,13 on intestinal motility seems to involve endogenous prostaglandins. 9 Conversely, the action of ILlI3 on gastric motility is inhibitory.10 Indeed, both central and systemic administrations of this cytokine induce a longlasting delay in rat gastric emptying, an action that is mediated through central IL1 receptors.'" The purpose of this study was to determine the effect of IL 1P on rat intestinal contractility in vitro and to investigate its mechanism of action more thoroughly. ) was applied and served as a control. A complete dose response curve to ACh (10-`to 10-3 M) was also established. Test substances were applied successively with repeated washings of 20 to 30 minutes between each concentration. The viability of each preparation was checked at the end of each experiment by controlling spontaneous mechanical activity and the response to 10-5 M ACh. Results were expressed as tension (g) and normalised for cross sectional area (CS), which was determined using the following equation13:
Methods
CS (mm2)=((tissue wet weight (mg)/ tissue length (mm)) Xdensity (mg/mm') A density of 1.05 was used according to Vermillon et al. 13 Experimental design In a first set of experiments, the effect of IL1 was studied on spontaneous and ACh induced contractility. ACh (10`M) was applied on the LM-MP jejunal preparation five, 90 or 150 minutes after incubation with IL13 (1-50 ng/ml). A dose response curve to ACh (10-9 to 10-3 M) was obtained in a cummulative manner after 90 minutes incubation with ILl ,B (10 ng/ml). ACh (10-5 M) was also applied on LM-MP ileal and colonic preparations five or 90 minutes after incubation with IL1 P (10 ng/ ml). To exclude an effect caused by possible endotoxin contamination, IL 130 (10 ng/ml) was boiled for 20 minutes before being added to the tissue. In a second set of experiments, the effect of potential inhibitory agents on the LM-MP jejunal motor response to ACh (10-5 M) was investigated before and after 90 minutes exposure to IL13 (10 ng/ml). The following drugs were used: cycloheximide (3.5X 10-4 M) to inhibit protein synthesis, Nw-nitro-L-arginine (L-NNA, 3 X 10-4 M) to inhibit nitric oxide synthase, and tetrodotoxin (TTX, 10-6 M) to block nervous transmission. L-NNA and cycloheximide were applied 15 and 20 minutes respectively before IL13; and TTX was added to the bath five minutes before application of IL1,B. In control experiments, a volume of Krebs-bicarbonated solution equal to the volume of the inhibitory agents used was added to the bath. All tested substances were administered in a volume that did not exceed 1% of the whole bath volume.
MEASUREMENT OF CONTRACTILE RESPONSE IN DISPERSED SMOOTH MUSCLE CELLS
Cell preparation Smooth muscle cells were isolated from LM-MP of rat jejunum using a modification of the method of Bitar et al, 4 as previously described.15
The LM-MP preparation was cut into small pieces and incubated at 37°C for three successive 30 minute periods in Ca2`-free phosphate buffer solution (PBS) containing 2% bovine serum albumin, 0.1% collagenase, and 0.1% soybean trypsin inhibitor. The pieces were washed in enzyme free PBS, and the cells were allowed to disperse under gentle pipette trituration. (Fig 1A and 1B) . A dose response curve to ACh was performed after 90 minutes exposure to IL 13P (10 ng/ml) showing that the inhibitory effect of IL1l 1 was maintained whatever the ACh concentration used (Fig 2) . Exposure of ileal and colonic segments to IL 13 (10 ng/ml) for 90 minutes significantly reduced ACh induced contraction (Fig 3A and 3B) .
Preincubation of the LM-MP preparations with 10 ng/ml of boiled IL113 did not affect the ACh (10-5 M) induced jejunal response (Fig 1A) .
The inhibiting action of ILl 1 was completely abolished by cycloheximide (3-5 X1O M), which however did not modify the contractile effect of ACh when given alone (Fig 4) . The nitric oxide synthase inhibitor L-NNA (3 X 10A M) did not prevent the inhibition caused by ILI ,B but increased the ACh response of smooth muscle when given alone (Fig 4) .
Blockade of neural transmission by TTX (10 6 
